280
Views
3
CrossRef citations to date
0
Altmetric
Retina

Process Mapping and Activity-Based Costing of the Intravitreal Injection Procedure

&
Pages 694-703 | Received 02 Jun 2020, Accepted 15 Sep 2020, Published online: 15 Oct 2020

References

  • Schmidt-Erfurth U, Loewenstein A, Moisseiev E, Grzybowski A, Told R, Sacu S, Bandello F. 2018 update on intravitreal injections: euretina expert consensus recommendations. Ophthalmologica. 2018;239(4):181–93. doi:10.1159/000486145.
  • Williams G. IVT injections: health policy implications. Rev Ophthalmol. 2014; 14(June): 62–64. https://www.reviewofophthalmology.com/article/ivt-injections-health-policy-implications
  • Lin J, Chang JS, Smiddy WE. Cost evaluation of panretinal photocoagulation versus intravitreal ranibizumab for proliferative diabetic retinopathy. Ophthalmology. 2016;123(9):1912–18. doi:10.1016/j.ophtha.2016.05.037.
  • Gibson D. The geographic distribution of eye care providers in the United States: implications for a national strategy to improve vision health. Prev Med. 2015;73:30–36. doi:10.1016/j.ypmed.2015.01.008.
  • Asbell RL Optimizing reimbursement in the face of medicare’s payment cuts. Retina Today. 2015:24–26.
  • Mack KA. Are you ready for reactivation of CMS’ injection bundles? Am Soc Retin Spec. 2014;1–4. https://www.asrs.org/advocacy/updates/262/are-you-ready-for-reactivation-of-cms-rsquo-injection-bundles
  • Williams GA Modifier – 25 under the microscope. Retina Today. 2017:21–22.
  • Federowicz MH, Grossman MN, Hayes BJ, Riggs JA. Tutorial on activity-based costing of electronic health records. Qual Manag Health Care. 2010;19(1):86–89. doi:10.1097/QMH.0b013e3181ccbd71.
  • Keel G, Savage C, Rafiq M, Mazzocato P. Time-driven activity-based costing in health care: A systematic review of the literature. Health Policy (New York). 2017;121(7):755–63. doi:10.1016/j.healthpol.2017.04.013.
  • Beriwal S, Chino J. Time-driven activity-based costing in oncology : a step in the right direction. Radiat Oncol Biol. 2018;100(1):95–96. doi:10.1016/j.ijrobp.2017.10.017.
  • Alves RJV, Etges APBDS, Neto GB, Polanczyk CA. Activity-based costing and time-driven activity-based costing for assessing the costs of cancer prevention, diagnosis, and treatment: a systematic review of the literature. Value Heal Reg Issues. 2018;17:142–47. doi:10.1016/j.vhri.2018.06.001.
  • Tan RYC, Met-Domestici M, Zhou K, Guzman AB, Lim ST, Soo KC, Feeley TW, Ngeow J. Using quality improvement methods and time-driven activity-based costing to improve value-based cancer care delivery at a cancer genetics clinic. J Oncol Pract. 2016;12(3):e320–e331. doi:10.1200/JOP.2015.007765.
  • Pascarella G, Capasso A, Nardone A, Triassi M, Pignata S, Arenare L, Ascierto P, Curvietto M, Maiolino P, D’Aniello R, et al. Costs of clinical trials with anticancer biological agents in an oncologic Italian cancer center using the activity-based costing methodology. Briel M, ed. PLoS One. 2019;14(1):e0210330. doi:10.1371/journal.pone.0210330.
  • Schutzer ME, Arthur DW, Anscher MS. Time-driven activity-based costing: a comparative cost analysis of whole-breast radiotherapy versus balloon-based brachytherapy in the management of early-stage breast cancer. J Oncol Pract. 2016;12(5):e584–e593. doi:10.1200/JOP.2015.008441.
  • Thaker NG, Frank SJ, Feeley TW. Comparative costs of advanced proton and photon radiation therapies: lessons from time-driven activity-based costing in head and neck cancer. J Comp Eff Res. 2015;4(4):297–301. doi:10.2217/cer.15.32.
  • Ning MS, Klopp AH, Jhingran A, Lin LL, Eifel PJ, Vedam S, Lawyer AA, Oliveri ND, Guzman AB, Incalcaterra JR, et al. Quantifying institutional resource utilization of adjuvant brachytherapy and intensity-modulated radiation therapy for endometrial cancer via time-driven activity-based costing. Brachytherapy. 2019;18(4):445–52. doi:10.1016/j.brachy.2019.03.003.
  • Laviana AA, Ilg AM, Veruttipong D, Tan H, Burke MA, Niedzwiecki DR, Kupelian PA, King CR, Steinberg ML, Kundavaram CR, et al. Utilizing time-driven activity-based costing to understand the short- and long-term costs of treating localized, low-risk prostate cancer. Cancer. 2016;122(3):447–55. doi:10.1002/cncr.29743.
  • Ilg AM, Laviana AA, Kamrava M, Veruttipong D, Steinberg M, Park S, Burke MA, Niedzwiecki D, Kupelian PA, Saigal C. Time-driven activity-based costing of low-dose-rate and high-dose-rate brachytherapy for low-risk prostate cancer. Brachytherapy. 2016;15(6):760–67. doi:10.1016/j.brachy.2016.08.008.
  • Lievens Y, van den Bogaert W, Kesteloot K. Activity-based costing: a practical model for cost calculation in radiotherapy. Int J Radiat Oncol Biol Phys. 2003;57(2):522–35. http://www.ncbi.nlm.nih.gov/pubmed/12957266.
  • Martino M, Console G, Russo L, Meliado A, Meliambro N, Moscato T, Irrera G, Messina G, Pontari A, Morabito F. Autologous stem cell transplantation in patients with multiple myeloma: an activity-based costing analysis, comparing a total inpatient model versus an early discharge model. Clin Lymphoma Myeloma Leuk. 2017;17(8):506–12. doi:10.1016/j.clml.2017.05.018.
  • Bauer-Nilsen K, Hill C, Trifiletti DM, Libby B, Lash DH, Lain M, Christodoulou D, Hodge C, Showalter TN. Evaluation of delivery costs for external beam radiation therapy and brachytherapy for locally advanced cervical cancer using time-driven activity-based costing. Int J Radiat Oncol Biol Phys. 2018;100(1):88–94. doi:10.1016/j.ijrobp.2017.09.004.
  • Helmers RA, Dilling JA, Chaffee CR, Larson M, Narr BJ, Haas DA, Kaplan RS. Overall cost comparison of gastrointestinal endoscopic procedures with endoscopist- or anesthesia-supported sedation by activity-based costing techniques. Mayo Clin Proc Innov Qual Outcomes. 2017;1(3):234–41. doi:10.1016/j.mayocpiqo.2017.10.002.
  • French KE, Guzman AB, Rubio AC, Frenzel JC, Feeley TW. Value based care and bundled payments: anesthesia care costs for outpatient oncology surgery using time-driven activity-based costing. Healthcare. 2016;4(3):173–80. doi:10.1016/j.hjdsi.2015.08.007.
  • Basto J, Chahal R, Riedel B. Time-driven activity-based costing to model the utility of parallel induction redesign in high-turnover operating lists. Healthcare. 2019;7(3):100355. doi:10.1016/j.hjdsi.2019.01.003.
  • Ridderstolpe L, Johansson A, Skau T, Rutberg H, Ahlfeldt H. Clinical process analysis and activity-based costing at a heart center. J Med Syst. 2002;26(4):309–22. doi:10.1023/a:1015816703951.
  • Erhun F, Mistry B, Platchek T, Milstein A, Narayanan VG, Kaplan RS. Time-driven activity-based costing of multivessel coronary artery bypass grafting across national boundaries to identify improvement opportunities: study protocol. BMJ Open. 2015;5(8):e008765. doi:10.1136/bmjopen-2015-008765.
  • Yun BJ, Prabhakar AM, Warsh J, Kaplan R, Brennan J, Dempsey KE, Raja AS. Time-driven activity-based costing in emergency medicine. Ann Emerg Med. 2016;67(6):765–72. doi:10.1016/j.annemergmed.2015.08.004.
  • Glick ND, Blackmore CC, Zelman WN. Extending simulation modeling to activity-based costing for clinical procedures. J Med Syst. 2000;24(2):77–89. doi:10.1023/a:1005564713255.
  • Heaton HA, Nestler DM, Barry WJ, Helmers RA, Sir MY, Goyal DG, Haas DA, Kaplan RS, Sadosty AT. A time-driven activity-based costing analysis of emergency department scribes. Mayo Clin Proc Innov Qual Outcomes. 2019;3(1):30–34. doi:10.1016/j.mayocpiqo.2018.11.004.
  • Balakrishnan K, Goico B, Arjmand EM. Applying cost accounting to operating room staffing in otolaryngology. Otolaryngol Neck Surg. 2015;152(4):684–90. doi:10.1177/0194599814568273.
  • Au J, Rudmik L. Cost of outpatient endoscopic sinus surgery from the perspective of the Canadian government: a time-driven activity-based costing approach. Int Forum Allergy Rhinol. 2013;3(9):748–54. doi:10.1002/alr.21181.
  • Crott R, Lawson G, Nollevaux MC, Castiaux A, Krug B. Comprehensive cost analysis of sentinel node biopsy in solid head and neck tumors using a time-driven activity-based costing approach. Eur Arch Oto-Rhino-Laryngology. 2016;273(9):2621–28. doi:10.1007/s00405-016-4089-z.
  • Cassettari L, Mosca M, Mosca R, Rolando F, Costa M, Pisaturo V. IVF cycle cost estimation using activity based costing and Monte Carlo simulation. Health Care Manag Sci. 2016;19(1):20–30. doi:10.1007/s10729-014-9282-2.
  • Husby KR, Tolstrup CK, Lose G, Klarskov N. Manchester–Fothergill procedure versus vaginal hysterectomy with uterosacral ligament suspension: an activity-based costing analysis. Int Urogynecol J. 2018;29(8):1161–71. doi:10.1007/s00192-018-3575-9.
  • Odhiambo J, Ruhumuriza J, Nkurunziza T, Riviello R, Shrime M, Lin Y, Rusangwa C, Omondi JM, Toma G, Nyirimodoka A, et al. Health facility cost of cesarean delivery at a rural district hospital in Rwanda using time-driven activity-based costing. Matern Child Health J. 2019;23(5):613–22. doi:10.1007/s10995-018-2674-z.
  • Kaplan AL, Agarwal N, Setlur NP, Tan HJ, Niedzwiecki D, McLaughlin N, Burke MA, Steinberg K, Chamie K, Saigal CS. Measuring the cost of care in benign prostatic hyperplasia using time-driven activity-based costing (TDABC). Healthcare. 2015;3(1):43–48. doi:10.1016/j.hjdsi.2014.09.007.
  • Isaacson D, Ahmad T, Metzler I, Tzou DT, Taguchi K, Usawachintachit M, Zetumer S, Sherer B, Stoller M, Chi T. Defining the costs of reusable flexible ureteroscope reprocessing using time-driven activity-based costing. J Endourol. 2017;31(10):1026–31. doi:10.1089/end.2017.0463.
  • Dugel PU, Tong KB. Development of an activity-based costing model to evaluate physician office practice profitability. Ophthalmology. 2011;118(1):203–208.e3. doi:10.1016/J.OPHTHA.2010.04.035.
  • Prenner JL, Halperin LS, Rycroft C, Hogue S, Williams Liu Z, Seibert R. Disease burden in the treatment of age-related macular degeneration: findings from a time-and-motion study. Am J Ophthalmol. 2015;160(4):725–731.e1. doi:10.1016/j.ajo.2015.06.023.
  • Murray TG, Tornambe P, Dugel P, Tong KB. Evaluation of economic efficiencies in clinical retina practice: activity-based cost analysis and modeling to determine impacts of changes in patient management. Clin Ophthalmol. 2011;5(1):913–25. doi:10.2147/OPTH.S22019.
  • Garoon RB, Lin WV, Young AK, Yeh AG, Chu YI, Weng CY. Cost savings analysis for a diabetic retinopathy teleretinal screening program using an activity-based costing approach. Ophthalmol Retin. 2018;2(9):906–13. doi:10.1016/j.oret.2018.01.020.
  • Cooper R, Kramer TR. Revenue-based cost assignment: A potent but hidden threat to the survival of the multispecialty medical practice. Acad Med. 2010;85(3):538–47. doi:10.1097/ACM.0b013e3181e204b5.
  • Hii BW, Mcnab AA, Friebel JDA. Comparison of external and endonasal dacryocystorhinostomy in regard to patient satisfaction and cost. Orbit. 2012;31(2):67–76. doi:10.3109/01676830.2011.648803.
  • Glasser DB, Parikh R, Lum F, Williams GA. Intravitreal anti-vascular endothelial growth factor cost savings achievable with increased bevacizumab reimbursement and utilization. Ophthalmology. 2020:1–5. doi:10.1016/j.ophtha.2020.06.012.
  • U.S. Centers for Medicare & Medicaid Services. NHE fact sheet; 2019. https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/NHE-Fact-Sheet.
  • Najjar PA, Strickland M, Kaplan RS. Time-driven activity-based costing for surgical episodes. JAMA Surg. 2017;152(1):96–97. doi:10.1001/jamasurg.2016.3356.
  • 5 top-paid medical specialties. Becker’s Hosp Rev. 2010. https://www.beckershospitalreview.com/compensation-issues/5-top-paid-medical-specialties.html.
  • Ciulla TA, Tatikonda MV, ElMaraghi YA, Hussain RM, Hill AL, Clary JM, Hattab E. Lean six sigma techniques to improve ophthalmology clinic efficiency. Retina. 2018;38(9):1688–98. doi:10.1097/IAE.0000000000001761.
  • Goldstein I, Hwang T, Gowrisankaran S, Bales R, Chiang M, Hribar M. Changes in electronic health record use time and documentation over the course of a decade. Ophthalmology. 2019;126(6):783–91. doi:10.1016/j.ophtha.2019.01.011.
  • Read-Brown S, Hribar MR, Reznick LG, Lombardi LH, Parikh M, Chamberlain WD, Bailey ST, Wallace JB, Yackel TR, Chiang MF. Time requirements for electronic health record use in an academic ophthalmology center. JAMA Ophthalmol. 2017;135(11):1250–57. doi:10.1001/jamaophthalmol.2017.4187.
  • Goldstein I, Hribar M, Reznick L, Chiang M. Analysis of total time requirements of electronic health record use by ophthalmologists using secondary EHR data. AMIA Annu Symp Proc. 2018;490–97.
  • Nemet AY, Geffen N, Nesher R, Mimouni M, Segal-Trivitz Y, Segal O. Survey of intravitreal injection techniques among retina specialists in Israel. Clin Ophthalmol. 2016;10:1111. doi:10.2147/opth.s96452.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.